J E Lewy

Tulane University, New Orleans, Louisiana, United States

Are you J E Lewy?

Claim your profile

Publications (49)264.3 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: When a partially obstructed kidney becomes infected, more rapid and extreme renal parenchymal damage appears to occur than might result from either infection or obstruction alone. Previously, we showed that either bacteriuria or partial obstruction in congenital unilateral hydronephrosis causes elevated renal pelvic pressures in a rat model. In this same model, we examined the combined effects of partial upper tract obstruction and bacteriuria on renal pelvic and bladder pressures. Female rats from an inbred colony in which more than one half are born with unilateral obstructive hydronephrosis were studied. Type 1 piliated Escherichia coli was instilled into the bladder. Two to 6 days later, the bladder and renal pelvic pressures were measured during varying urinary flows (less than 2 to more than 30 mL/kg/hr). All animals were killed and the kidneys and bladder grossly and histologically assessed. Hydronephrosis was determined at pathologic examination. Eight rats had congenital unilateral hydronephrosis; five were normal. Acute inflammation was found in all bladder and renal specimens. In hydronephrotic, infected kidneys, the renal pelvic pressures exceeded those in nonhydronephrotic, infected kidneys at all urinary flow rates. Bladder capacity and pressures did not differ between the two groups. This model demonstrates that the combination of infection and obstructive hydronephrosis in this model causes renal pelvic pressure elevation that is higher than that associated with either infection or obstructive hydronephrosis alone. These data demonstrate the compound effect that infection and obstruction may have on the kidney and offers an explanation for why this clinical situation is more likely to be associated with greater renal parenchymal injury than either alone.
    Full-text · Article · May 2003 · Urology

  • No preview · Article · Apr 1999 · The Journal of Urology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated whether oxybutynin could lower elevated renal pelvic pressures measured in a rat with an inbred unilateral congenital hydronephrosis. Simultaneous renal pelvic and bladder pressures were measured in 8 hydronephrotic rats and compared to those of 10 hydronephrotic rats treated with intravenous injection of 1.6 mg./kg. oxybutynin. Pressures were recorded at different urinary flow rates and during bladder filling and emptying. Hydronephrotic rats not given oxybutynin showed significantly higher renal pelvic pressures (e.g. p-bladder at 50% capacity = 8.9 +/- 3.1 cm. H2O, corresponding p-pelvis = 20.8 +/- 2.1 at very high urinary flow rates) than rats treated with oxybutynin. The latter had renal pelvic pressures similar to rats with normal non-hydronephrotic kidneys (e.g. p-bladder at 50% capacity = 10.1 +/- 3.5 cm. H2O, corresponding p-pelvis = 6.3 +/- 1.1 at very high urinary flow rates). Renal pelvic pressures were, moreover, lower than corresponding bladder pressures in contrast to the untreated hydronephrotic pelvic pressure that exceeded bladder pressure. This effect of oxybutynin in lowering elevated renal pelvic pressures in the obstructed kidney has not been described before and suggests a possible role for oxybutynin in this condition.
    Full-text · Article · Oct 1998 · The Journal of Urology
  • F G Boineau · J E Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: Most children with an identifiable cause of hematuria will be properly diagnosed if an appropriate evaluation is completed. However, some children with persistent hematuria will not have an identifiable cause. This article provides clinical advice on properly diagnosing the child.
    No preview · Article · Oct 1997 · Comprehensive Therapy
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Since new ultrafast magnetic resonance imaging (MRI) might offer unique advantages for evaluating renal blood flow, anatomy and urinary excretion, we used this technique to characterize a rat model with congenital partial ureteropelvic junction obstruction. MRI of 9 rats from an inbred colony with unilateral congenital (nonsurgical) hydronephrosis was compared with the contralateral nonhydronephrotic kidney serving as control. Our new imaging technique consisted of a 1-minute ultrafast gradient recalled imaging sequence during the first minute (64 images per imaging time 960 milliseconds) after contrast bolus injection with gadolinium-diethylenetriaminepentaacetic acid for assessment of renal blood flow followed by a 30-minute period with image acquisition every 30 seconds to study contrast distribution and excretion. Signal intensities were analyzed continuously over selected, different regions of interest. Anatomic analysis of MRI noncontrast studies showed precise delineation of the hydronephrotic pelvis and corticomedullary junction. After contrast gadolinium-diethylenetriaminepentaacetic acid injection signal intensity from the region of interest from hydronephrotic kidneys differed from nonhydronephrotic kidneys by showing less cortical decrease, suggesting decreased blood flow, less medullary decrease and delayed contrast excretion. Clear contrast distribution among the cortex, medulla and collecting system allowed selective estimation of different regions of interest and excellent anatomic evaluation. Renal anatomy and renal pelvic pressures were confirmed after scans were completed. Ultrafast contrast enhanced MRI allows simultaneous assessment of renal morphology, blood flow and function. In hydronephrotic partially obstructed kidneys distinct flow and excretion patterns measured with contrast enhanced MRI allow differentiation between the obstructed and nonobstructed kidney on physiological rather than purely anatomic means. This imaging technique may provide a useful method of evaluating congenital hydronephrosis obviating the need for multiple different diagnostic procedures.
    Full-text · Article · Sep 1994 · The Journal of Urology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated a rat model with inbred unilateral congenital hydronephrosis. Simultaneous bladder and renal pelvic pressures were measured during different urinary flows, and during bladder filling and voiding in these congenitally hydronephrotic rats (approximately 45 days old) and normal nonhydronephrotic rats from the same colony. Differential pressures between pelvis and proximal ureter were determined. Upon termination of the experiment the urinary tract was removed and processed for histological examination. Hydronephrotic rats had significantly higher renal pelvic pressures throughout bladder filling at all urinary flow rates than normal rats. These elevated renal pelvic pressures exceeded bladder pressures at high flows (for example bladder pressure at 50% capacity was 8.9 +/- 3.1 cm. water and corresponding pelvic pressure was 20.8 +/- 2.1 [hydronephrosis] versus pelvic pressure 7.4 +/- 1.1 [control]). While pressures in the proximal ureter were higher than in the pelvis in normal rats the hydronephrotic rats showed significantly higher pressures in the pelvis, suggesting that the site of obstruction is the ureteropelvic junction. Histological evaluation of the excised kidneys revealed only minimal tubular changes. This study represents a unique animal model with unilateral hydronephrosis from a partially obstructing ureteropelvic junction. Moreover, the data indicate that partial urinary obstruction and the associated renal pelvic pressures should be defined with reference to bladder fullness and urinary flow rates.
    Full-text · Article · Sep 1994 · The Journal of Urology
  • Source
    Basil G Hanss · John E Lewy · Richard C Vari
    [Show abstract] [Hide abstract]
    ABSTRACT: We have previously shown that rats with congenital, unilateral hydronephrosis exhibit a reduction in GFR that returns to normal when either the renin angiotensin system or thromboxane A2 (TxA2) is blocked. The current study defines the single nephron defect in congenital, unilateral hydronephrosis and evaluates the roles of angiotensin II (Ang II) and TxA2 in this renal derangement. Renal micropuncture experiments were performed on the right kidney of rats from an inbred colony with unilateral right-sided hydronephrosis (HYDRO), or non-affected litter mates (CONTROL). In addition, four separate groups of hydronephrotic animals were treated with either the TxA2 receptor antagonist SQ-29548 (SQ), one of two Ang II receptor antagonists [saralasin (SAR) or DuP-753 (DUP)]; or combined treatment with DuP-753 and SQ-29,548 (S&D). SNGFR was significantly reduced (P < 0.05) in HYDRO compared to CONTROL (17.6 +/- 2.0 vs. 35.9 +/- 3.7 nl/min, respectively). Treatment with SQ-29,548 normalized SNGFR (29.0 +/- 3.0 nl/min), while saralasin and DuP-753 resulted in only a partial recovery of function (25.6 +/- 1.6 and 27.8 +/- 1.4 nl/min, respectively). Combined SQ-29,548 and DuP-753 treatment resulted in full recovery of SNGFR to 32.9 +/- 4.4 nl/min. The glomerular ultrafiltration coefficient (Kf) was reduced (P < 0.05) approximately 45% in HYDRO compared to CONTROL (1.64 +/- .08 vs. 2.84 +/- .22 nl/min/mm Hg, respectively). Kf returned to control levels in SAR, DUP and SQ, and increased above control in S&D (5.58 +/- 1.6 nl/min/mm Hg). There were no differences (P > 0.05) in hydrostatic or oncotic pressures across the glomerular capillary between any of the groups studied. The observation that Kf increases above CONTROL with combined blockade of TxA2 and Ang II suggests that these regulatory hormones decrease Kf via independent mechanisms. These data indicate that the reduction in SNGFR in congenital, unilateral hydronephrosis is a result of a marked fall in Kf that is mediated by both Ang II and TxA2.
    Preview · Article · Jul 1994 · Kidney International
  • Source
    R C Vari · F G Boineau · J E Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: A technique for the measurement of GFR without collection of urine in rats was experimentally validated and applied to experiments designed to: (1) evaluate the degree of reduction of GFR in rats with congenital, unilateral hydronephrosis; and (2) to determine if the reduction in renal function is mediated by angiotensin II and/or thromboxane A2 mechanisms. Simultaneous measurements of GFR by a constant-infusion technique and the traditional inulin clearance technique in rats with either one or two normal kidneys were highly correlated (r = 0.934; P < 0.001; N = 17). GFR was approximately 24% lower (P < 0.001) in rats with congenital unilateral hydronephrosis than in rats with a normal kidney. The GFR in rats with hydronephrosis infused with a receptor blocker for either angiotensin II or thromboxane A2 was greater than the GFR in hydronephrotic kidneys without blockade and was not significantly different (P > 0.05) from that in rats with normal kidneys. These results indicate that a constant inulin infusion technique without urine collections can be used to accurately measure GFR in congenitally hydronephrotic kidneys, rendering values free from possible residual pelvic volume artifact. In addition, these results also indicate that a significant 24% reduction in GFR occurs in congenital unilateral hydronephrosis and is mediated by angiotensin II and thromboxane A2 mechanisms.
    Full-text · Article · Mar 1993 · Journal of the American Society of Nephrology
  • F G Boineau · J E Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the normal physiologic losses of water and electrolytes from the body, the source of the loss, and the increased body loss of water associated with fever. The three different methods for estimating replacement of water and electrolyte losses are described in this review.
    No preview · Article · May 1990 · Pediatric Clinics of North America

  • No preview · Article · Mar 1990 · Journal of Pediatrics
  • Source
    F G Boineau · J E Lewy

    Full-text · Article · Nov 1989 · Pediatrics in Review
  • R Baliga · R W Chesney · F G Boineau · J E Lewy

    No preview · Article · Nov 1988 · Pediatric Nephrology
  • Frank G. Boineau · Richard C. Vari · John E. Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: We studied the effects of inhibition of either prostaglandins or the role of prostanoids and the renin-angiotensin system on renal function in rats with congenital unilateral hydronephrosis. Wistar rats with congenital unilateral hydronephrosis were infused with normal saline (control), captopril dissolved in normal saline or indomethacin dissolved in a solution of sodium chloride and sodium carbonate. In the control group both glomerular filtration rate (GFR) and effective renal plasma flow were reduced in the right hydronephrotic kidney (RHK) compared with the normal left kidney. Indomethacin did not improve renal function in the RHK. Captopril significantly improved GFR in the RHK. These results support the conclusion that the renin-angiotensin system is an important mediator of reduced GFR in congenital unilateral hydronephrosis in rats.
    No preview · Article · Aug 1987 · Pediatric Nephrology
  • R Baliga · J E Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: Edema results from excess accumulation of interstitial fluid. This may be due to increased transfer of fluid across the capillary membranes or excess retention of salt and water. The kidneys play a significant role in promoting salt and water homeostasis. Correction of the primary disorder should be the main goal in the management. Diuretics aid in promoting increased excretion of salt and water.
    No preview · Article · Jul 1987 · Pediatric Clinics of North America
  • [Show abstract] [Hide abstract]
    ABSTRACT: The relative roles of erythropoietin and potential inhibitors of erythropoiesis in the development of anemia in children with renal disease have been studied. Thirty-five children with renal disease of varied origins and severity were compared with 30 children with anemia of similar severity and with normal renal function. Serum erythropoietin was measured by radioimmunoassay; erythroid (CFU-E) and granulocytic (CFU-GM) progenitor cell growth were assessed in fetal mouse liver cell and normal human bone marrow cell cultures, respectively. The degree of serum inhibition of in vitro CFU-E growth in children with renal disease correlated with both creatinine clearance (r = 0.59, P less than 0.001) and hematocrit level (r = 0.55, P less than 0.005). Serum from children with renal disease inhibited in vitro CFU-E growth in a dose-related manner. Normal serum did not inhibit CFU-E growth in culture. The mean serum erythropoietin concentration was significantly (P less than 0.025) higher in children with anemia of renal disease (32.4 +/- 2.4 mU/ml) in comparison with serum values in normal children (19.6 +/- 1.5 mU/ml), but serum erythropoietin levels did not correlate with hematocrit level, creatinine clearance, or serum inhibition of in vitro erythropoiesis. In contrast, children with anemia and normal renal function showed a significant (P less than 0.001) linear increase in serum erythropoietin concentration (range 28.7 to 327 mU/ml), increased reticulocyte count, and stimulation of CFU-E formation with decreasing hematocrit levels. Coincubation of human urinary erythropoietin in the presence of serum from patients with uremia revealed markedly less immunoreactivity in the radioimmunoassay and less biologic activity in the fetal mouse liver CFU-E assay for erythropoietin than when erythropoietin was incubated with normal human serum, suggesting some alteration of erythropoietin in the presence of uremic serum, which reduced both the immunologic and biologic activity of erythropoietin. Normal and uremic sera inhibited CFU-GM growth to the same degree in comparison with controls. In conclusion, relative erythropoietin deficiency, direct alteration in the biologic activity of erythropoietin by uremic toxins, and serum inhibition of erythroid progenitor cells in the bone marrow are probably important factors in the pathogenesis of anemia in children with renal disease.
    No preview · Article · May 1985 · Journal of Laboratory and Clinical Medicine
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The relative roles of erythropoietin (Ep) deficiency and PTH excess in the development of anemia in children with chronic renal failure (CRF) have been assessed. Serum Ep in 71 patients (PTS) was determined by radioimmunoassay (RIA). Seven were studied in the predialysis stage, 32 on hemodialysis, 16 on CAPD and 16 on CCPD. The mean serum Ep was 38.1±3.5 mu/ml with anemia of renal disease (predialysis and dialysis PTS) compared to 19.6±1.5 mu/ml in normals. However, when compared to 30 children with anemia of non-renal origin, the elevation in Ep (range 28.7-327 mu/ml) was significantly below that expected for the degree of anemia in these renal disease PTS. We also found a direct inhibitory effect of uremic serum on both immunologic and biologic activity of Ep itself. Co-incubation of Ep (50, 100, or 200 mu/ml) with uremic serum resulted in markedly lower RIA values for these three concentrations of Ep compared to normal serum. Biologic activity as assessed in the fetal mouse liver CFU-E assay was also decreased with uremic serum. Serum PTH levels, although elevated, did not correlate with the degree of anemia. In conclusion although relative Ep deficiency plays a primary role in the anemia of CRF other factors which alter Ep itself and inhibit erythroid progenitors appear to be involved.
    Full-text · Article · Apr 1985 · Pediatric Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: The erythropoietin response to anaemia was compared in 30 children with haemolytic anaemia and in 5 children with Fanconi's hypoproliferative anaemia. Serum erythropoietin was measured by radioimmunoassay. In children with haemolytic anaemia the serum erythropoietin concentration increased exponentially with decreasing haematocrit values (r = 0.74; p less than 0.001). Serum erythropoietin levels also correlated with reticulocyte counts (r = 0.62; p less than 0.001). Children with Fanconi's hypoproliferative anaemia had considerably higher serum erythropoietin levels than children with haemolysis for the same degree of anaemia. These data indicate that erythropoietin production in Fanconi's anaemia may be dependent on other factors in addition to the degree of anaemia and relative hypoxaemia.
    No preview · Article · Feb 1985 · Acta Haematologica

  • No preview · Article · Dec 1982 · Prostaglandins
  • F G Boineau · J E Lewy

    No preview · Article · Sep 1981 · Pediatric Annals
  • N Rahman · F G Boineau · J E Lewy
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute renal failure (ARF) is defined as a sudden deterioration in renal function leading to reduced glomerular filtration rate (GFR), decreased urine output or anuria, and usually fluid and electrolyte disturbances. A presumptive diagnosis of ARF in a neonate can be made if urine output is less than 1 ml per kg body weight per hour, lasting for 24 hours and/or serum creatinine above 1.0 mg per dl or BUN above 20 mg per dl. Because the period of observation from birth to suspicion of ARF is short, congenital malformations are usually grouped within a classification of ARF. Congenital malformations are obviously chronic but may cause symptoms of ARF after birth. Urine may be found in the bladder of human fetuses as early as the fourth month of fetal life. But during intrauterine life the placenta is the major excretory organ. Therefore even neonates with bilateral renal agenesis are not uremic at birth. Ninety-three per cent of normal neonates pass urine within 24 hours of birth and 99.4 per cent within 48 hours. Thus, failure to pass urine within the first 24 hours of life may be a normal physiologic variant, but in such cases oliguria should be suspected and urine output closely monitored. in cases of ARF due to acute tubular necrosis (ATN), the period of oliguria may be so short as to escape attention or it may last for two to three weeks.
    No preview · Article · Jul 1981 · Clinics in Perinatology

Publication Stats

606 Citations
264.30 Total Impact Points


  • 1980-2003
    • Tulane University
      • • Department of Pediatrics
      • • Department of Medicine
      • • Department of Pharmacology
      New Orleans, Louisiana, United States
  • 1994
    • Stanford Medicine
      • Department of Urology
      Stanford, California, United States
  • 1990
    • The University of Tennessee Health Science Center
      Memphis, Tennessee, United States
  • 1974-1979
    • Cornell University
      • Department of Pediatrics
      Итак, New York, United States
  • 1976
    • Weill Cornell Medical College
      New York, New York, United States
  • 1972
    • University of Chicago
      Chicago, Illinois, United States